Jessani, S., Saleem, S., Hoffman, M., Goudar, S., Derman, R., Moore, J., . . . Liechty, E. (2021). Association of haemoglobin levels in the first trimester and at 26–30 weeks with fetal and neonatal outcomes: A secondary analysis of the Global Network for Women's and Children's Health's ASPIRIN Trial. BJOG: An International Journal of Obstetrics & Gynaecology, 128(9), 1487. https://doi.org/10.1111/1471-0528.16676
Chicago Style (17th ed.) CitationJessani, S., et al. "Association of Haemoglobin Levels in the First Trimester and at 26–30 weeks with Fetal and Neonatal Outcomes: A Secondary Analysis of the Global Network for Women's and Children's Health's ASPIRIN Trial." BJOG: An International Journal of Obstetrics & Gynaecology 128, no. 9 (2021): 1487. https://doi.org/10.1111/1471-0528.16676.
MLA (9th ed.) CitationJessani, S., et al. "Association of Haemoglobin Levels in the First Trimester and at 26–30 weeks with Fetal and Neonatal Outcomes: A Secondary Analysis of the Global Network for Women's and Children's Health's ASPIRIN Trial." BJOG: An International Journal of Obstetrics & Gynaecology, vol. 128, no. 9, 2021, p. 1487, https://doi.org/10.1111/1471-0528.16676.